Report cover image

Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029

Publisher MarketsandMarkets
Published Mar 12, 2024
Length 370 Pages
SKU # MKMK18627945

Description

Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029



The gene expression analysis market is projected to reach USD 6.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 8.1% during the forecast period.

The growth of this market can be attributed to the growing investments in genomics research and the availability of government funding for genetic studies further contributes to the market's expansion. As the field continues to evolve, with a deeper understanding of gene regulation and molecular mechanisms, the gene expression analysis market is poised for continued growth and innovation.

“The PCR instrument segment accounted for the largest share by instruments in 2023.”

In 2023, the PCR segment accounted for the largest share of instruments sub-segment of product & service in the global gene expression analysis market. PCR instruments are widely adopted across various industries, including pharmaceuticals, biotechnology, academic research, clinical diagnostics, and forensic sciences. This broad application range contributes to the substantial market share of PCR instruments.

““The Asia Pacific region is grows at the highest CAGR in the gene expression analysis market during the forecast period of 2024-2029.”

The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. This region is s anticipated to experience rapid growth, fueled by expanding proteomics and genomics research, augmented research funding, amplified investments from pharmaceutical and biotechnology enterprises, and rising awareness surrounding personalized therapeutics. India and China are expected to display the highest growth in the Asia Pacific region, particularly due to the rise in affordability and awareness related to the benefits of diagnosis.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%

By Designation: Managers - 45%, CXOs and Directors - 30%, and Executives- 25%

By Region: North America -45%, Europe -20%, Asia-Pacific -20%, Latin America -10%, Middle East & Africa- 5%

List of Companies Profiled in the Report:

Thermo Fisher Scientific Inc (US)

Bio-Rad Laboratories Inc. (US)

Illumina Inc (US)

QIAGEN (Netherlands)

F. Hoffmann-La Roche (Switzerland)

Revvity (US)

PacBio (US)

Agilent Technologies Inc (US)

Oxford Gene Technology IP Limited (UK)

BGI (China)

Eurofins Scientific (Luxembourg)

Standard BioTools (US)

Oxford Nanopore Technologies plc (UK)

GenScript (US)

Takara Bio Inc (Japan)

10x Genomics (US)

Zymo Research Corporation (US)

Twist Bioscience (US)

Promega Corporation (US)

LGC Limited (UK)

CD Genomics (US)

NanoString Technologies Inc. (US)

BioSpyder, Inc (US)

Integrated DNA Technologies, Inc (US)

New England Biolabs (US).

Research Coverage:

This research report categorizes the gene expression analysis market by product & service (instruments, reagents & consumables and services (gene expression analysis service and bioinformatics service)), application (clinical diagnostics, drug discovery & development, and other applications (developmental biology, pharmacogenomics, environmental response, forensic research, agricultural research)) , end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users (clinical laboratories, CROs, forensic laboratories, agricultural & environmental organizations)), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and trends influencing the growth of the gene expression analysis market. The report conducts in-depth analysis of major industry players, offering insights into their business profiles, product/service offerings, and strategic initiatives including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments within the gene expression analysis market. Furthermore, it encompasses competitive analysis of leading players as well as emerging startups within the gene expression analysis market ecosystem.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall gene expression analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Advancement in gene editing technologies, increasing funding initiatives for genomic research, growing preference for therapeutic application, declining sequencing cost), restraints (high cost of instruments & consumables, concerns associated with data privacy and security), opportunities (application expansion across non-medical fields, machine learning and ai, growing focus on single-cell analysis), and challenges (prolonged timelines for approval, data interpretation challenges) influencing the growth of the market.

Product Development/Innovation: Detailed insights on newly launched products of the gene expression analysis market

Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.

Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the gene expression analysis market

Competitive Assessment: Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories Inc. (US), Illumina Inc (US), QIAGEN (Netherlands), F. Hoffmann-La Roche (Switzerland), Revvity (US), PacBio (US), Agilent Technologies Inc (US), Oxford Gene Technology IP Limited (UK), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc (Japan), 10x Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), NanoString Technologies Inc. (US), BioSpyder, Inc (US), Integrated DNA Technologies, Inc (US) and New England Biolabs (US), among others in the market.

Table of Contents

370 Pages
    • STUDY OBJECTIVES
    • MARKET DEFINITION
    • MARKET SCOPE
    • RESEARCH LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
    • RECESSION IMPACT
    • RESEARCH DATA
    • MARKET SIZE ESTIMATION
    • GROWTH RATE ASSUMPTIONS
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • STUDY ASSUMPTIONS
    • RISK ANALYSIS
    • RECESSION IMPACT ANALYSIS
  • EXECUTIVE SUMMARY
    • GENE EXPRESSION ANALYSIS MARKET OVERVIEW
    • NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023
    • GENE EXPRESSION ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE, 2024 VS. 2029
    • GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • INTRODUCTION
    • MARKET DYNAMICS
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    • PRICING ANALYSIS
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM ANALYSIS
    • TECHNOLOGY ANALYSIS
    • PATENT ANALYSIS
    • TRADE DATA
    • KEY CONFERENCES & EVENTS
    • REGULATORY LANDSCAPE
    • PORTER’S FIVE FORCES ANALYSIS
    • KEY STAKEHOLDERS AND BUYING CRITERIA
    • INTRODUCTION
    • REAGENTS & CONSUMABLES
    • INSTRUMENTS
    • SERVICES
    • INTRODUCTION
    • DRUG DISCOVERY & DEVELOPMENT
    • CLINICAL DIAGNOSTICS
    • OTHER APPLICATIONS
    • INTRODUCTION
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • ACADEMIC & RESEARCH INSTITUTES
    • OTHER END USERS
    • INTRODUCTION
    • NORTH AMERICA
    • EUROPE
    • ASIA PACIFIC
    • LATIN AMERICA
    • MIDDLE EAST
    • AFRICA
    • INTRODUCTION
    • RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • REVENUE SHARE ANALYSIS
    • MARKET SHARE ANALYSIS
    • COMPANY EVALUATION MATRIX: KEY PLAYERS
    • COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS
    • COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
    • VALUATION AND FINANCIAL METRICS OF GENE EXPRESSION ANALYSIS VENDORS
    • BRAND/PRODUCT COMPARATIVE ANALYSIS
    • COMPETITIVE SCENARIO
    • KEY PLAYERS
    • OTHER PLAYERS
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us